本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ligand Pharmaceuticals Inc.

109.39
+0.24000.22%
盘后109.390.00000.00%16:05 EDT
成交量:8.11万
成交额:891.46万
市值:21.09亿
市盈率:-496.22
高:111.42
开:110.85
低:108.50
收:109.15
数据加载中...
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

重要事件披露

8-K - Current report
2021/01/28

重要事件披露

8-K - Current report
2021/01/27

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/01/27

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/06

SEC问询函

CORRESP [Cover] - Correspondence
2020/12/21

重要事件披露

8-K - Current report
2020/12/16

重要事件披露

8-K - Current report
2020/12/10

重要事件披露

8-K/A [Amend] - Current report
2020/12/03

重要事件披露

8-K - Current report
2020/11/23

重要事件披露

8-K - Current report
2020/11/06

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]